Press Releases VLI receives Phase II MIPS grant The grant will be used to develop therapeutic vaccines for viral liver diseases Wednesday, July 22, 2009   VLI receives National Cancer Institute Phase II grant The grant will be used to develop a novel next generation breast cancer product. Wednesday, September 17, 2008   VLI receives MIPS grant The grant will be used to develop therapeutic vaccines for viral liver diseases Thursday, February 21, 2008   Qyntessa Biologics to develop cell line with VectorLogics Monday, May 5, 2007 Media Coverage Virotherapy in spotlight again, in use at bedside BIRMINGHAM, AL.; UAB Reporter Online Thursday, September 11, 2008   Gene therapy anti-cancer research featured in Scientific American BIRMINGHAM, AL. – Scientific American magazine focused on two University of Alabama at Birmingham (UAB) Comprehensive Cancer Center researchers in a news story on experimental next-generation anti-cancer therapies. Sunday, August 24, 2008   UAB to lead pioneering cancer trial Ovarian cancer patients in the study to be treated with tumor-killing virus. Sunday, March 25, 2007